Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival

Abstract

Our preliminary data support the hypothesis that over-expression of cortactin, contained in the 11q13 amplicon, is involved in osteosarcoma carcinogenesis. The potential of cortactin overexpression as a biomarker for osteosarcoma is consolidated.